slotkoers
Shenzhen S.E.
00:00:00 20-06-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
7,41
CNY
|
+1,65%
|
|
+2,63%
|
-24,23%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
3.076
|
2.906
|
2.689
|
3.122
|
3.094
|
2.882
|
Bedrijfswaarde
1 |
2.609
|
2.407
|
2.063
|
2.595
|
2.302
|
1.936
|
K/w-verhouding
|
17
x
|
31,7
x
|
25,6
x
|
28,2
x
|
22
x
|
-234
x
|
Dividendrendement
|
0,96%
|
1,52%
|
1,07%
|
-
|
0,95%
|
1,02%
|
Marktkapitalisatie/omzet
|
3,06
x
|
2,12
x
|
2,29
x
|
1,99
x
|
2,12
x
|
2,96
x
|
Bedrijfswaarde/omzet
|
2,6
x
|
1,76
x
|
1,76
x
|
1,66
x
|
1,57
x
|
1,99
x
|
Bedrijfswaarde/EBITDA
|
9,69
x
|
10,7
x
|
8,58
x
|
10,8
x
|
7,85
x
|
12,2
x
|
Bedrijfswaarde/FCF
|
-114
x
|
5,46
x
|
42,1
x
|
-936
x
|
11
x
|
14,1
x
|
FCF Yield
|
-0,87%
|
18,3%
|
2,38%
|
-0,11%
|
9,06%
|
7,08%
|
Price to Book
|
1,95
x
|
1,76
x
|
1,57
x
|
1,68
x
|
1,53
x
|
1,45
x
|
Aantal aandelen (in duizenden)
|
294.683
|
294.683
|
286.694
|
294.283
|
294.683
|
294.683
|
Referentieprijs
2 |
10,44
|
9,860
|
9,380
|
10,61
|
10,50
|
9,780
|
Datum van publicatie
|
27/03/19
|
27/04/20
|
30/03/21
|
24/03/22
|
29/03/23
|
18/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
1.005
|
1.370
|
1.173
|
1.565
|
1.462
|
972,9
|
EBITDA
1 |
269,3
|
225,9
|
240,6
|
240,6
|
293,2
|
159
|
Bedrijfsresultaat (EBIT)
1 |
189,6
|
113,3
|
127,7
|
124,8
|
169,8
|
23,97
|
Operationele Marge
|
18,86%
|
8,27%
|
10,88%
|
7,97%
|
11,61%
|
2,46%
|
Resultaat voor belastingen (EBT)
1 |
212,1
|
116,4
|
130,6
|
129,9
|
153,1
|
6,052
|
Nettowinst (verlies)
1 |
178,6
|
89,93
|
105,6
|
111,4
|
140,3
|
-12,31
|
Nettomarge
|
17,76%
|
6,56%
|
9%
|
7,12%
|
9,6%
|
-1,27%
|
WPA
2 |
0,6135
|
0,3109
|
0,3659
|
0,3760
|
0,4762
|
-0,0418
|
Free Cash Flow
1 |
-22,82
|
440,6
|
49,04
|
-2,774
|
208,5
|
137,1
|
FCF-marge
|
-2,27%
|
32,15%
|
4,18%
|
-0,18%
|
14,26%
|
14,09%
|
Kasstroomconversie (ebitda)
|
-
|
195,01%
|
20,39%
|
-
|
71,12%
|
86,24%
|
Kasstroomconversie (nettowinst)
|
-
|
489,87%
|
46,46%
|
-
|
148,58%
|
-
|
Dividend per aandeel
2 |
0,1007
|
0,1500
|
0,1000
|
-
|
0,1000
|
0,1000
|
Datum van publicatie
|
27/03/19
|
27/04/20
|
30/03/21
|
24/03/22
|
29/03/23
|
18/04/24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
467
|
499
|
626
|
527
|
792
|
946
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-22,8
|
441
|
49
|
-2,77
|
209
|
137
|
ROE (netto-inkomsten/eigen vermogen)
|
12,1%
|
6,55%
|
6,84%
|
6,31%
|
6,54%
|
-1,37%
|
ROA (netto-inkomsten/totale activa)
|
6,76%
|
3,69%
|
3,92%
|
3,51%
|
4,51%
|
0,63%
|
Totale activa
1 |
2.644
|
2.436
|
2.694
|
3.178
|
3.115
|
-1.961
|
Nettoactief per aandeel
2 |
5,360
|
5,620
|
5,970
|
6,330
|
6,850
|
6,730
|
Cashflow per aandeel
2 |
0,0800
|
0,4100
|
0,3900
|
0,3200
|
0,9300
|
1,110
|
Capex
1 |
269
|
134
|
104
|
63
|
149
|
121
|
Capex/omzet
|
26,8%
|
9,81%
|
8,9%
|
4,03%
|
10,19%
|
12,41%
|
Datum van publicatie
|
27/03/19
|
27/04/20
|
30/03/21
|
24/03/22
|
29/03/23
|
18/04/24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -24,23% | 301 mln. | | +51,99% | 798 mld. | | -5,72% | 356 mld. | | +18,94% | 328 mld. | | +11,07% | 304 mld. | | +16,96% | 244 mld. | | +2,25% | 227 mld. | | +11,15% | 216 mld. | | +7,59% | 166 mld. | | -3,65% | 157 mld. |
Farmaceutische producten - Andere
|